O

Ovid Therapeutics
D

OVID

1.30000
USD
0.00
(0.00%)
Market Closed
Volume
9,266
EPS
0
Div Yield
0
P/E
-3
Market Cap
92,263,050
Related Instruments
    A
    ALT
    -0.27000
    (-4.24%)
    6.10000 USD
    B
    BNTX
    -5.530
    (-6.42%)
    80.570 USD
    C
    CRVS
    0.36000
    (13.85%)
    2.96000 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    N
    NVAX
    -0.250
    (-1.95%)
    12.560 USD
    O
    OCGN
    -0.11500
    (-8.21%)
    1.28500 USD
    V
    VBIV
    -0.00920
    (-7.34%)
    0.11610 USD
    V
    VXRT
    -0.01170
    (-1.74%)
    0.65890 USD
    More
News

Title: Ovid Therapeutics

Sector: Healthcare
Industry: Biotechnology
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with apotential in-class mechanism of action.